Diabetes mellitus is one of the leading causes of morbidity and mortality in many countries and is considered as one of the epidemics of the twenty-first century. Current diabetes treatment is mostly based around daily insulin injection. Pancreas or islet transplantation first appeared as a good alternative, but lack of donor calls for more reliable clinical approaches. Recently, stem cell-based therapies have emerged as promising alternatives for pancreatic regenerative medicine. This chapter will review recent innovative clinical and preclinical applications used for diabetes treatment ranging from insulin injection to newly established cellular clinical trials with umbilical cord stem cells.
CITATION STYLE
Le Roy, H., Forraz, N., Jurga, M., & McGuckin, C. P. (2013). Umbilical cord stem cells for pancreatic regenerative medicine. In Human Fetal Tissue Transplantation (pp. 269–284). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-4171-6_21
Mendeley helps you to discover research relevant for your work.